Observational studyFrontiers in endocrinology2024

Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing's syndrome.

Yasutaka Tsujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.